Childhood myopia — nearsightedness — has gone from a relatively uncommon refractive error to a global epidemic in a single generation. The reason it matters isn't just stronger glasses every year. Higher levels of myopia carry real lifelong risks: retinal detachment, glaucoma, and myopic macular degeneration all become more common as myopia progresses.
The good news is that modern optometry has several evidence-based tools that can meaningfully slow how nearsighted a child becomes — sometimes cutting the progression rate in half. Here's what works.
Why myopia progression matters
Myopia happens when the eye grows too long, focusing images in front of the retina instead of on it. Glasses correct the resulting blur, but they don't slow the underlying growth. And each step of progression — each additional diopter of myopia — adds risk for the eye later in life.
High myopia (roughly −6.00 diopters or more) is associated with a significantly higher lifetime risk of serious eye disease. So the goal of myopia control isn't perfect vision today; it's a healthier eye for the next 60 years.
1. Time outdoors
Children who spend more time outdoors develop myopia at lower rates and progress more slowly once they do. The threshold from research is approximately 90 minutes a day. The exact mechanism isn't fully nailed down — bright light, distant focus, and circadian factors all likely play a role — but the effect is consistent across studies.
This is the easiest, cheapest, and most underused myopia intervention. If you only do one thing for a young child, this is the one.
2. Low-dose atropine drops
Atropine drops at concentrations of 0.05% or 0.025% (much lower than the dilating drops you've experienced at an eye exam) have been shown in large multi-year studies to slow myopia progression with minimal side effects when used once nightly.
The drops don't fix the existing myopia — they slow how fast it gets worse. They're well-tolerated by most children, easy to administer, and one of the most accessible options for families.
3. Orthokeratology
Ortho-k uses custom rigid contact lenses worn overnight to temporarily reshape the cornea. The child takes the lenses out in the morning and sees clearly all day without glasses or contacts. The reshaping is fully reversible — stop wearing them and the eye returns to baseline within days.
Beyond the convenience of glasses-free vision during the day, ortho-k has solid evidence for slowing axial elongation. It demands proper hygiene and follow-up, so it's a commitment, but for the right child the daily benefits are substantial.
4. Specialty soft contact lenses and spectacle lenses
MiSight 1 day soft contact lenses are FDA-approved for myopia control in children, with clinical-trial evidence of meaningful slowing. They're worn during the day like any daily disposable contact lens.
Multifocal soft contact lenses with specific treatment zones are also commonly prescribed off-label for myopia control with good evidence.
On the spectacle side, lens designs called DIMS (defocus incorporated multiple segments) and HAL (highly aspherical lenslet) have demonstrated meaningful effects in studies and are increasingly available. For families uncomfortable with contacts on a young child, these are a major step forward.
Combining treatments
Many myopia-control specialists combine approaches — for instance, low-dose atropine alongside ortho-k or specialty soft contacts — to maximize effect. The best protocol for a given child depends on age, rate of progression, lifestyle, family preferences, and how the eye responds. An optometrist with experience in myopia control should walk you through the options without pressure.
Start sooner, not later
The earlier a child starts a myopia-control treatment, the more they tend to benefit. If your child has been getting stronger glasses each year, don't wait — schedule a consultation specifically about myopia management.
Standard glasses and contacts correct the blur but don't slow the disease. That's a meaningful difference for a six- or eight-year-old who has decades of eye growth still ahead.